Tomarong, Hazel .

HRN: 09-92-82  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2023
CEFUROXIME 1.5GM (VIAL)
06/16/2023
06/17/2023
IV
1.5
Q8
1 LTCS
Waiting Final Action 
06/16/2023
CEFUROXIME 500MG (TAB)
06/17/2023
06/22/2023
PO
500
Bid
LTCS, Primary
Waiting Final Action 
06/16/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/16/2023
06/18/2023
IV
500
Q8
1° LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: